InBioGen Co Ltd (101140) - Cash Flow Conversion Efficiency
Based on the latest financial reports, InBioGen Co Ltd (101140) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.67 Billion ≈ $-1.13 Million USD) by net assets (₩170.78 Billion ≈ $115.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
InBioGen Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how InBioGen Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read InBioGen Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
InBioGen Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of InBioGen Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Frontier Nuclear and Minerals Inc.
NASDAQ:FNUC
|
N/A |
|
RTG Mining Inc
AU:RTG
|
0.000x |
|
Datagate Bilgisayar Malzemeleri Ticaret AS
IS:DGATE
|
1.726x |
|
Country Group Holdings Public Company Limited
BK:CGH
|
-0.037x |
|
Talaad Thai Leasehold Property Fund
BK:TTLPF
|
0.039x |
|
Chang Type Industrial Co Ltd
TW:1541
|
0.021x |
|
Quartiers Properties AB (publ)
ST:QUART-PREF
|
0.048x |
|
Powertech Industrial Co Ltd
TW:3296
|
-0.016x |
Annual Cash Flow Conversion Efficiency for InBioGen Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of InBioGen Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see InBioGen Co Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩159.84 Billion ≈ $108.32 Million |
₩-33.13 Million ≈ $-22.45K |
0.000x | +97.07% |
| 2023-12-31 | ₩148.68 Billion ≈ $100.76 Million |
₩-1.05 Billion ≈ $-712.04K |
-0.007x | +93.59% |
| 2022-12-31 | ₩104.42 Billion ≈ $70.76 Million |
₩-11.51 Billion ≈ $-7.80 Million |
-0.110x | -177.48% |
| 2021-12-31 | ₩178.02 Billion ≈ $120.64 Million |
₩-7.07 Billion ≈ $-4.79 Million |
-0.040x | +61.49% |
| 2020-12-31 | ₩77.91 Billion ≈ $52.80 Million |
₩-8.03 Billion ≈ $-5.44 Million |
-0.103x | -77.77% |
| 2019-12-31 | ₩66.00 Billion ≈ $44.72 Million |
₩-3.83 Billion ≈ $-2.59 Million |
-0.058x | +20.27% |
| 2018-12-31 | ₩23.35 Billion ≈ $15.83 Million |
₩-1.70 Billion ≈ $-1.15 Million |
-0.073x | -93.19% |
| 2017-12-31 | ₩11.32 Billion ≈ $7.67 Million |
₩-426.44 Million ≈ $-288.99K |
-0.038x | -162.82% |
| 2016-12-31 | ₩5.75 Billion ≈ $3.90 Million |
₩344.75 Million ≈ $233.63K |
0.060x | +104.27% |
| 2015-12-31 | ₩7.80 Billion ≈ $5.29 Million |
₩-10.96 Billion ≈ $-7.43 Million |
-1.405x | -732.60% |
| 2014-12-31 | ₩4.12 Billion ≈ $2.79 Million |
₩-695.95 Million ≈ $-471.63K |
-0.169x | +45.32% |
| 2013-12-31 | ₩3.67 Billion ≈ $2.49 Million |
₩-1.13 Billion ≈ $-767.47K |
-0.309x | -- |
About InBioGen Co Ltd
INBIOGEN Co., Ltd. engages in the manufacture and distribution of footwear products in South Korea. It is also involved in distribution of wood pellets; kiosk; and food and beverage businesses. The company was formerly known as BTONE CO.,Ltd. INBIOGEN Co., Ltd. was founded in 1949 and is headquartered in Seoul, South Korea.